{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:51:13Z","timestamp":1793677873449,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Avian A(H5N1) influenza virus poses an elevated zoonotic threat to humans, and no pharmacological products are currently registered for fast-acting pre-exposure protection in case of spillover leading to a pandemic. Here, we show that an epitope on the stem domain of H5 hemagglutinin is highly conserved and that the human monoclonal antibody CR9114, targeting that epitope, potently neutralizes all pseudotyped H5 viruses tested, even in the rare case of substitutions in its epitope. Further, intranasal administration of CR9114 fully protects mice against A(H5N1) infection at low dosages, irrespective of pre-existing immunity conferred by the quadrivalent seasonal influenza vaccine. These data provide a proof-of-concept for broad, pre-exposure protection against a potential future pandemic using the intranasal administration route. Studies in humans should assess if autonomous administration of a broadly-neutralizing monoclonal antibody is safe and effective and can thus contribute to pandemic preparedness.<\/jats:p>","DOI":"10.1038\/s41598-024-53049-5","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T15:03:07Z","timestamp":1708009387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration"],"prefix":"10.1038","volume":"14","author":[{"given":"Anna L.","family":"Beukenhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Frallicciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keira L.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Koldijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana C.","family":"Moreira de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaco M.","family":"Klap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoforos","family":"Hadjichrysanthou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa M.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A. S.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Vietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertjan","family":"Ziere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Julg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Goudsmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"9","key":"53049_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2023.28.9.2300134","volume":"28","author":"H Nishiura","year":"2023","unstructured":"Nishiura, H., Kayano, T., Hayashi, K., Kobayashi, T. & Okada, Y. Letter to the Editor: Knowledge gap in assessing the risk of a human pandemic via mammals\u2019 infection with highly pathogenic avian influenza A(H5N1). Eurosurveillance 28(9), 1. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.9.2300134 (2023).","journal-title":"Eurosurveillance"},{"issue":"3","key":"53049_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2903\/j.efsa.2023.7917","volume":"21","author":"C Adlhoch","year":"2023","unstructured":"Adlhoch, C. et al. Avian influenza overview December 2022\u2013March 2023. EFSA J. 21(3), 1. https:\/\/doi.org\/10.2903\/j.efsa.2023.7917 (2023).","journal-title":"EFSA J."},{"issue":"1","key":"53049_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/22221751.2022.2155072","volume":"12","author":"J Shi","year":"2023","unstructured":"Shi, J., Zeng, X., Cui, P., Yan, C. & Chen, H. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg. Microbes Infect. 12(1), 1. https:\/\/doi.org\/10.1080\/22221751.2022.2155072 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"53049_CR4","unstructured":"World Health Organization, \u201cHuman infection with avian influenza A(H5) viruses Human infection with avian influenza A(H5N1) virus.,\u201d Avian Influ. Wkly. Updat. Number 886, 2023, [Online]. Available: https:\/\/www.who.int\/docs\/default-source\/wpro---documents\/emergency\/surveillance\/avian-influenza\/ai_20230310.pdf?sfvrsn=22ea0816_25."},{"issue":"7","key":"53049_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2023.28.7.2300085","volume":"28","author":"E de Vries","year":"2023","unstructured":"de Vries, E. & de Haan, C. A. Letter to the editor: Highly pathogenic influenza A(H5N1) viruses in farmed mink outbreak contain a disrupted second sialic acid binding site in neuraminidase, similar to human influenza A viruses. Eurosurveillance 28(7), 1. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.7.2300085 (2023).","journal-title":"Eurosurveillance"},{"issue":"4","key":"53049_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3201\/eid2904.221538","volume":"29","author":"W Puryear","year":"2023","unstructured":"Puryear, W. et al. Highly pathogenic avian influenza A(H5N1) virus outbreak in New England seals, United States. Emerg. Infect. Dis. 29(4), 786\u2013791. https:\/\/doi.org\/10.3201\/eid2904.221538 (2023).","journal-title":"Emerg. Infect. Dis."},{"issue":"6088","key":"53049_CR7","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1213362","volume":"336","author":"S Herfst","year":"2012","unstructured":"Herfst, S. et al. Airborne transmission of influenza A\/H5N1 virus between ferrets. Science 336(6088), 1534\u20131541. https:\/\/doi.org\/10.1126\/science.1213362 (2012).","journal-title":"Science"},{"key":"53049_CR8","doi-asserted-by":"publisher","unstructured":"Mahase, E. H5N1: Do we need to worry about the latest bird flu outbreaks? BMJ 401. https:\/\/doi.org\/10.1136\/bmj.p401 (2023).","DOI":"10.1136\/bmj.p401"},{"issue":"2","key":"53049_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/spid.2002.122999","volume":"13","author":"JA Englund","year":"2002","unstructured":"Englund, J. A. Antiviral therapy of influenza. Semin. Pediatr. Infect. Dis. 13(2), 120\u2013128. https:\/\/doi.org\/10.1053\/spid.2002.122999 (2002).","journal-title":"Semin. Pediatr. Infect. Dis."},{"issue":"14","key":"53049_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou, B., Zhong, N. & Guan, Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N. Engl. J. Med. 357(14), 1450\u20131451. https:\/\/doi.org\/10.1056\/NEJMc070359 (2007).","journal-title":"N. Engl. J. Med."},{"key":"53049_CR11","unstructured":"Center for Disease Control and Prevention, \u201cTechnical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses.,\u201d 2023, [Online]. Available: https:\/\/www.cdc.gov\/flu\/avianflu\/spotlights\/2022-2023\/h5n1-technical-report.htm"},{"issue":"3","key":"53049_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.vaccine.2018.11.069","volume":"37","author":"CM Oshansky","year":"2019","unstructured":"Oshansky, C. M. et al. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Vaccine 37(3), 435\u2013443. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.069 (2019).","journal-title":"Vaccine"},{"key":"53049_CR13","unstructured":"UK Health Security Agency, \u201cUKHSA announces new UK-based vaccine deal,\u201d 2023, [Online]. Available: https:\/\/www.gov.uk\/government\/news\/ukhsa-announces-new-uk-based-vaccine-deal"},{"issue":"3","key":"53049_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10654-023-00965-x","volume":"38","author":"AL Beukenhorst","year":"2023","unstructured":"Beukenhorst, A. L. SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies. Eur. J. Epidemiol. 38, 3, 237-242. https:\/\/doi.org\/10.1007\/s10654-023-00965-x (2023).","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"53049_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038463","volume":"11","author":"JH Beigel","year":"2021","unstructured":"Beigel, J. H. & Hayden, F. G. Influenza therapeutics in clinical practice\u2014challenges and recent advances. Cold Spring Harb. Perspect. Med. 11(4), a038463. https:\/\/doi.org\/10.1101\/cshperspect.a038463 (2021).","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6100","key":"53049_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science (80-) 337(6100), 1343\u20131348. https:\/\/doi.org\/10.1126\/science.1222908 (2012).","journal-title":"Science (80-)"},{"key":"53049_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fviro.2022.1049134","volume":"2","author":"AL Beukenhorst","year":"2022","unstructured":"Beukenhorst, A. L. et al. The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection. Front. Virol. 2, 1. https:\/\/doi.org\/10.3389\/fviro.2022.1049134 (2022).","journal-title":"Front. Virol."},{"key":"53049_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.71393","volume":"10","author":"AM Phillips","year":"2021","unstructured":"Phillips, A. M. et al. Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies. Elife 10, 1. https:\/\/doi.org\/10.7554\/eLife.71393 (2021).","journal-title":"Elife"},{"issue":"W1","key":"53049_CR19","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkab314","volume":"49","author":"D Sehnal","year":"2021","unstructured":"Sehnal, D. et al. Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures. Nucleic Acids Res. 49(W1), W431\u2013W437. https:\/\/doi.org\/10.1093\/nar\/gkab314 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"53049_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/10810730500531422","volume":"11","author":"SC Ratzan","year":"2006","unstructured":"Ratzan, S. C. The bird (to Human) flu epidemic\u2014If or When?. J. Health Commun. 11(2), 131\u2013132. https:\/\/doi.org\/10.1080\/10810730500531422 (2006).","journal-title":"J. Health Commun."},{"issue":"12","key":"53049_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003942","volume":"3","author":"M Throsby","year":"2008","unstructured":"Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3(12), e3942. https:\/\/doi.org\/10.1371\/journal.pone.0003942 (2008).","journal-title":"PLoS One"},{"issue":"7","key":"53049_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0103550","volume":"9","author":"R Roozendaal","year":"2014","unstructured":"Roozendaal, R. et al. Transient humoral protection against H5N1 challenge after seasonal influenza vaccination of humans. PLoS One 9(7), 1. https:\/\/doi.org\/10.1371\/journal.pone.0103550 (2014).","journal-title":"PLoS One"},{"issue":"2","key":"53049_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"Y-Q Chen","year":"2018","unstructured":"Chen, Y.-Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173(2), 417-429.e10. https:\/\/doi.org\/10.1016\/j.cell.2018.03.030 (2018).","journal-title":"Cell"},{"issue":"1","key":"53049_CR24","doi-asserted-by":"publisher","first-page":"e03617","DOI":"10.1128\/mBio.03617-20","volume":"12","author":"EK Roubidoux","year":"2021","unstructured":"Roubidoux, E. K. et al. Mutations in the hemagglutinin stalk domain do not permit escape from a protective, stalk-based vaccine-induced immune response in the mouse model. MBio 12(1), e03617-e3620 (2021).","journal-title":"MBio"},{"issue":"7","key":"53049_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9070741","volume":"9","author":"JMM Del Rosario","year":"2021","unstructured":"Del Rosario, J. M. M. et al. Exploiting pan influenza a and pan influenza b pseudotype libraries for efficient vaccine antigen selection. Vaccines 9(7), 1. https:\/\/doi.org\/10.3390\/vaccines9070741 (2021).","journal-title":"Vaccines"},{"key":"53049_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1184362","volume":"14","author":"D Cantoni","year":"2023","unstructured":"Cantoni, D. et al. Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Front. Immunol. 14, 1. https:\/\/doi.org\/10.3389\/fimmu.2023.1184362 (2023).","journal-title":"Front. Immunol."},{"key":"53049_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1162342","volume":"14","author":"S Esposito","year":"2023","unstructured":"Esposito, S. et al. Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the It. Front. Immunol. 14, 1. https:\/\/doi.org\/10.3389\/fimmu.2023.1162342 (2023).","journal-title":"Front. Immunol."},{"issue":"3","key":"53049_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1046\/j.1365-2249.1998.00538.x","volume":"111","author":"M Ramisse","year":"2001","unstructured":"Ramisse, M. et al. Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab\u2032)2 fragments. Clin. Exp. Immunol. 111(3), 583\u2013587. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00538.x (2001).","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"53049_CR29","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1128\/AAC.00290-15","volume":"59","author":"VH Leyva-Grado","year":"2015","unstructured":"Leyva-Grado, V. H., Tan, G. S., Leon, P. E., Yondola, M. & Palese, P. Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies. Antimicrob. Agents Chemother. 59(7), 4162\u20134172. https:\/\/doi.org\/10.1128\/AAC.00290-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53049_CR30","doi-asserted-by":"publisher","unstructured":"Vigil, A., et al. Airway delivery of anti-influenza monoclonal antibodies results in enhanced antiviral activities and enables broad-coverage combination therapies downloaded from, vol. 94, pp. 52\u201372 (2020). https:\/\/doi.org\/10.1128\/JVI.","DOI":"10.1128\/JVI"},{"issue":"1","key":"53049_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virusres.2013.05.006","volume":"178","author":"M Baz","year":"2013","unstructured":"Baz, M., Luke, C. J., Cheng, X., Jin, H. & Subbarao, K. H5N1 vaccines in humans. Virus Res. 178(1), 78\u201398. https:\/\/doi.org\/10.1016\/j.virusres.2013.05.006 (2013).","journal-title":"Virus Res."},{"issue":"6","key":"53049_CR32","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40121-022-00710-z","volume":"11","author":"C Hadjichrysanthou","year":"2022","unstructured":"Hadjichrysanthou, C. Exploring the role of antiviral nasal sprays in the control of emerging respiratory infections in the community. Infect. Dis. Ther. 11(6), 2287\u20132296. https:\/\/doi.org\/10.1007\/s40121-022-00710-z (2022).","journal-title":"Infect. Dis. Ther."},{"issue":"5","key":"53049_CR33","doi-asserted-by":"publisher","first-page":"L1002","DOI":"10.1152\/ajplung.00260.2003","volume":"286","author":"C Lombry","year":"2004","unstructured":"Lombry, C., Edwards, D. A., Pr\u00e9at, V. & Vanbever, R. Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules. Am. J. Physiol. Cell. Mol. Physiol. 286(5), L1002\u2013L1008. https:\/\/doi.org\/10.1152\/ajplung.00260.2003 (2004).","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"issue":"9\u201310","key":"53049_CR34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.addr.2006.07.015","volume":"58","author":"AJ Bitonti","year":"2006","unstructured":"Bitonti, A. J. & Dumont, J. A. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv. Drug Deliv. Rev. 58(9\u201310), 1106\u20131118. https:\/\/doi.org\/10.1016\/j.addr.2006.07.015 (2006).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"53049_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"Claxton, A. J., Cramer, J. & Pierce, C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23(8), 1296\u20131310. https:\/\/doi.org\/10.1016\/S0149-2918(01)80109-0 (2001).","journal-title":"Clin. Ther."},{"issue":"1","key":"53049_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/2041-210X.12628","volume":"8","author":"G Yu","year":"2017","unstructured":"Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T. ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8(1), 28\u201336. https:\/\/doi.org\/10.1111\/2041-210X.12628 (2017).","journal-title":"Methods Ecol. Evol."},{"issue":"2","key":"53049_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/molbev\/msz240","volume":"37","author":"L-G Wang","year":"2020","unstructured":"Wang, L.-G. et al. Treeio: An R package for phylogenetic tree input and output with richly annotated and associated data. Mol. Biol. Evol. 37(2), 599\u2013603. https:\/\/doi.org\/10.1093\/molbev\/msz240 (2020).","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"53049_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/mps1010008","volume":"1","author":"F Ferrara","year":"2018","unstructured":"Ferrara, F. & Temperton, N. Pseudotype neutralization assays: From laboratory bench to data analysis. Methods Protoc. 1(1), 8. https:\/\/doi.org\/10.3390\/mps1010008 (2018).","journal-title":"Methods Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53049-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53049-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53049-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T23:11:28Z","timestamp":1708297888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53049-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53049-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ALB, JF, KLR, JMK, MHK, BAdJ, HV, BZ, JCMdM, CMK, BJ, WK, JG disclose that they are employees of Leyden Laboratories with stock options in this company. Other authors (CH, KdC, NT) have not reported any conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3818"}}